BioCryst Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
BCRX Nasdaq 2830 www.biocryst.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioCryst Pharmaceuticals, Inc.

PHVS Stock Rises 10% in a Month: What Is Driving the Rally? - Sep 15th, 2026 7:50 am
BioCryst Pharmaceuticals (BCRX) Could Be 62% Undervalued On Its ORLADEYO Growth Story - Sep 14th, 2026 10:10 am
Sector Update: Healthcare Stocks Softer in Afternoon Trading - Sep 10th, 2026 11:45 am
BCRX Stock Heads For Fifth Straight Day In The Red – RBC Capital Says BioCryst Faces A ‘Challenging Near-Term Outlook’ - Sep 10th, 2026 9:52 am
BioCryst Pharmaceuticals Faces Competitive Pressure in Hereditary Angioedema Treatment, RBC Says - Sep 10th, 2026 9:42 am
BCRX Stock Posts Worst Day In Over 6 Months After PHVS Trial Win In Rare Swelling Disease - Sep 8th, 2026 5:24 pm
CareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease Portfolio - Sep 8th, 2026 2:45 pm
Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow It - Sep 6th, 2026 6:50 am
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks - Sep 2nd, 2026 7:15 am
BioCryst to Present at Upcoming Investor Conference - Sep 1st, 2026 5:00 am
Is BioCryst Pharmaceuticals (BCRX) Stock Outpacing Its Medical Peers This Year? - Aug 31st, 2026 7:40 am
BioCryst’s Orladeyo Built The Cash Pile, CEO Gayer Wants To Buy The Next Asset - Aug 28th, 2026 5:40 pm
Wall Street Analysts Think BioCryst (BCRX) Could Surge 108.21%: Read This Before Placing a Bet - Aug 28th, 2026 7:55 am
BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan - Aug 25th, 2026 5:01 am
Why Did BioCryst Pharmaceuticals (BCRX) Shares Climb After Its Latest Update? - Aug 13th, 2026 3:10 am
BioCryst Pharmaceuticals (BCRX) Stock Looks Cheap Even After A 53% Gain - Aug 13th, 2026 1:53 am
BioCryst (BCRX) Q2 2026 Earnings Call Transcript - Aug 12th, 2026 11:29 am
Wall Street Analysts See a 98.74% Upside in BioCryst (BCRX): Can the Stock Really Move This High? - Aug 12th, 2026 7:55 am
Implied Volatility Surging for BioCryst Pharmaceuticals Stock Options - Aug 11th, 2026 8:43 am